Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHIRON GAINING 350-PERSON CIBA CORNING SALES FORCE FOR LAUNCH OF bDNA PROBES

This article was originally published in The Gray Sheet

Executive Summary

CHIRON GAINING 350-PERSON CIBA CORNING SALES FORCE FOR LAUNCH OF bDNA PROBES under development by Chiron. Chiron's acquisition of Ciba Corning Diagnostics (CCD), which will be effected as part of an agreement that will give Ciba-Geigy a 49.9% stake in Chiron, will provide Chiron with an established sales group and customer and distribution base for the commercial introduction of its Quantiplex branched DNA (bDNA) signal amplification technology diagnostics. CCD, which had sales of about $98 mil. in 1993, supplements its sales organization with a 300-person service group.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003118

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel